EUVIMEDEUVIMED entdecken
Crossref

Thrombotic microangiopathy in patients with malignant hypertension

Teresa Cavero, Pilar Auñón, Fernando Caravaca-Fontán iD, Hernando Trujillo iD, Emi Arjona, Enrique Morales iD, Elena Guillén, Miquel Blasco iD, Cristina Rabasco, Mario Espinosa, Marta Blanco, Catuxa Rodríguez-Magariños und 9 weitere

Nephrology Dialysis Transplantation · 04.05.2023 · 38 (5) · 1217-1226

DOI: 10.1093/ndt/gfac248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 24.08.2022. Verfasst von Teresa Cavero und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain. Hauptthemen laut MEDLINE: Hypertension, Malignant, Thrombotic Microangiopathies, Purpura, Thrombotic Thrombocytopenic, Atypical Hemolytic Uremic Syndrome. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional, Ministerio de Ciencia, Innovación y Universidades.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thrombotic microangiopathy (TMA) is a complication of malignant hypertension (mHTN) attributed to high blood pressure (BP). However, no studies have investigated in patients with mHTN of different aetiologies whether the presence of TMA is associated with specific causes of mHTN.

Methods

We investigated the presence of TMA (microangiopathic haemolytic anaemia and thrombocytopenia) in a large and well-characterized cohort of 199 patients with mHTN of different aetiologies [primary HTN 44%, glomerular diseases 16.6%, primary atypical haemolytic uraemic syndrome (aHUS) 13.1%, renovascular HTN 9.5%, drug-related HTN 7%, systemic diseases 5.5%, endocrine diseases 4.5%]. Outcomes of the study were kidney recovery and kidney failure.

Results

Patients with TMA [40 cases (20.1%)] were younger, were more likely female and had lower BP levels and worse kidney function at presentation. Their underlying diseases were primary aHUS (60%), drug-related mHTN (15%), glomerular diseases [all of them immunoglobulin A nephropathy (IgAN); 10%], systemic diseases (10%) and primary HTN (5%). The presence of TMA was 92.3% in primary aHUS, 42.9% in drug-related HTN, 36.4% in systemic diseases, 12.1% in glomerular diseases and 2.3% in primary HTN. No patient with renovascular HTN or mHTN caused by endocrine diseases developed TMA, despite BP levels as high as patients with TMA. A higher proportion of TMA patients developed kidney failure as compared with patients without TMA (56.4% versus 38.9%, respectively).

Conclusions

The presence of TMA in patients with mHTN should guide the diagnosis towards primary aHUS, drug-related mHTN, some systemic diseases and IgAN, while it is exceptional in other causes of mHTN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, MalignantThrombotic MicroangiopathiesPurpura, Thrombotic ThrombocytopenicAtypical Hemolytic Uremic SyndromeKidney DiseasesRenal InsufficiencyHypertensionHumansFemaleKidney

Stichwörter der Autor:innen

blood pressurekidney failuremalignant hypertensionthrombotic microangiopathy

Autor:innen und Institutionen

  • Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Research Institute Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Centro de Investigación Biomédica en Red en Enfermedades Raras, Madrid, Spain.
  • Department of Nephrology and Renal Transplantation, Hospital Clínic, Centro de Referencia en Enfermedad Glomerular Compleja del Sistema Nacional de Salud de España, Department of Medicine, University of Barcelona, Barce…
  • Department of Nephrology, Hospital Universitario Reina Sofía, Córdoba, Spain.
  • Department of Nephrology, Hospital Universitario A Coruña, A Coruña, Spain.

ORCID-Profile: Fernando Caravaca-Fontán, Hernando Trujillo, Enrique Morales, Miquel Blasco, Ana Huerta

Förderung

  • Instituto de Salud Carlos III
  • Fondo Europeo de Desarrollo Regional
  • Ministerio de Ciencia, Innovación y Universidades
  • Ministerio de Economía y Competitividad

Zitieren

APA

Cavero, T., Auñón, P., Caravaca-Fontán, F., Trujillo, H., Arjona, E., Morales, E., Guillén, E., Blasco, M., Rabasco, C., Espinosa, M., Blanco, M., Rodríguez-Magariños, C., Cao, M., Ávila, A., Huerta, A., Rubio, E., Cabello, V., Barros, X., Goicoechea de Jorge, E., …, & Praga, M. (2023). Thrombotic microangiopathy in patients with malignant hypertension. Nephrology Dialysis Transplantation, 38(5), 1217-1226. https://doi.org/10.1093/ndt/gfac248

Vancouver

Cavero T, Auñón P, Caravaca-Fontán F, Trujillo H, Arjona E, Morales E, et al. Thrombotic microangiopathy in patients with malignant hypertension. Nephrology Dialysis Transplantation. 2023;38(5):1217-1226. doi:10.1093/ndt/gfac248

BibTeX
@article{Cavero2023,
  author = {Cavero, Teresa and Auñón, Pilar and Caravaca-Fontán, Fernando and Trujillo, Hernando and Arjona, Emi and Morales, Enrique and Guillén, Elena and Blasco, Miquel and Rabasco, Cristina and Espinosa, Mario and Blanco, Marta and Rodríguez-Magariños, Catuxa and Cao, Mercedes and Ávila, Ana and Huerta, Ana and Rubio, Esther and Cabello, Virginia and Barros, Xoana and Goicoechea de Jorge, Elena and Rodríguez de Córdoba, Santiago and Praga, Manuel},
  title = {Thrombotic microangiopathy in patients with malignant hypertension},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  volume = {38},
  number = {5},
  pages = {1217--1226},
  doi = {10.1093/ndt/gfac248}
}
Kostenlos starten →